Pathway analysis of genome-wide association study on serum prostate-specific antigen levels

Gene

Volumn 551, Issue 1, 2014, Pages 86-91

  Ge, Yu Zheng ^a   Xu, Zheng ^a   Xu, Lu Wei ^a   Yu, Peng ^b   Zhao, Yan ^c   Xin, Hui ^a   Wu, Ran ^a   Tan, Si Jia ^a   Song, Qun ^a   Wu, Jian Ping ^a   Li, Wen Cheng ^a   Zhu, Jia Geng ^a   Jia, Rui Peng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

^c JIANGSU UNIVERSITY   (China)

Author keywords

Genome wide association study; Pathway analysis; Prostate specific antigen

Indexed keywords

AMINO ACID; PROSTATE SPECIFIC ANTIGEN; ACTIN BINDING PROTEIN; CHLORIDE CHANNEL; CISD1 PROTEIN, HUMAN; CLIC5 PROTEIN, HUMAN; CYTOCHROME P450; MITOCHONDRIAL PROTEIN; RETINOIC ACID 4-HYDROXYLASE; T BOX TRANSCRIPTION FACTOR; TBX1 PROTEIN, HUMAN;

ARTICLE; CAUCASIAN; CELL CYCLE M PHASE; ENDOCRINE SYSTEM; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; MEIOSIS; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; GENETICS; HAPLOTYPE MAP; METABOLISM;

CHLORIDE CHANNELS; CYTOCHROME P-450 ENZYME SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENOME-WIDE ASSOCIATION STUDY; HAPMAP PROJECT; HUMANS; MALE; MICROFILAMENT PROTEINS; MITOCHONDRIAL PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; T-BOX DOMAIN PROTEINS;

EID: 84907522146     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.08.044     Document Type: Article

References (45)

1. Adzhubei I., Jordan D.M., Sunyaev S.R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 2013, 7:20.1-20.41.
2. Altshuler D.M., Gibbs R.A., Peltonen L., Dermitzakis E., Schaffner S.F., Yu F., Bonnen P.E., de Bakker P.I., Deloukas P., Gabriel S.B., Gwilliam R., Hunt S., Inouye M., Jia X., Palotie A., Parkin M., Whittaker P., Chang K., Hawes A., Lewis L.R., Ren Y., Wheeler D., Muzny D.M., Barnes C., Darvishi K., Hurles M., Korn J.M., Kristiansson K., Lee C., McCarrol S.A., Nemesh J., Keinan A., Montgomery S.B., Pollack S., Price A.L., Soranzo N., Gonzaga-Jauregui C., Anttila V., Brodeur W., Daly M.J., Leslie S., McVean G., Moutsianas L., Nguyen H., Zhang Q., Ghori M.J., McGinnis R., McLaren W., Takeuchi F., Grossman S.R., Shlyakhter I., Hostetter E.B., Sabeti P.C., Adebamowo C.A., Foster M.W., Gordon D.R., Licinio J., Manca M.C., Marshall P.A., Matsuda I., Ngare D., Wang V.O., Reddy D., Rotimi C.N., Royal C.D., Sharp R.R., Zeng C., Brooks L.D., McEwen J.E. Integrating common and rare genetic variation in diverse human populations. Nature 2010, 467:52-58.
3. Bansal A., Murray D.K., Wu J.T., Stephenson R.A., Middleton R.G., Meikle A.W. Heritability of prostate-specific antigen and relationship with zonal prostate volumes in aging twins. J. Clin. Endocrinol. Metab. 2000, 85:1272-1276.
4. Carter H.B., Albertsen P.C., Barry M.J., Etzioni R., Freedland S.J., Greene K.L., Holmberg L., Kantoff P., Konety B.R., Murad M.H., Penson D.F., Zietman A.L. Early detection of prostate cancer: AUA Guideline. J. Urol. 2013, 190:419-426.
5. Cooper G.M., Shendure J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet. 2011, 12:628-640.
6. Crawford E.D., Abrahamsson P.A. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests?. Eur. Urol. 2008, 54:262-273.
7. Duan S., Luo X., Dong C. Identification of susceptibility modules for coronary artery disease using a genome wide integrated network analysis. Gene 2013, 531:347-354.
8. Edwards S.L., Beesley J., French J.D., Dunning A.M. Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 2013, 93:779-797.
9. Flicek P., Aken B.L., Ballester B., Beal K., Bragin E., Brent S., Chen Y., Clapham P., Coates G., Fairley S., Fitzgerald S., Fernandez-Banet J., Gordon L., Graf S., Haider S., Hammond M., Howe K., Jenkinson A., Johnson N., Kahari A., Keefe D., Keenan S., Kinsella R., Kokocinski F., Koscielny G., Kulesha E., Lawson D., Longden I., Massingham T., McLaren W., Megy K., Overduin B., Pritchard B., Rios D., Ruffier M., Schuster M., Slater G., Smedley D., Spudich G., Tang Y.A., Trevanion S., Vilella A., Vogel J., White S., Wilder S.P., Zadissa A., Birney E., Cunningham F., Dunham I., Durbin R., Fernandez-Suarez X.M., Herrero J., Hubbard T.J., Parker A., Proctor G., Smith J., Searle S.M. Ensembl's 10th year. Nucleic Acids Res. 2010, 38:D557-D562.
10. Fransen K., Franzen P., Magnuson A., Elmabsout A.A., Nyhlin N., Wickbom A., Curman B., Torkvist L., D'Amato M., Bohr J., Tysk C., Sirsjo A., Halfvarson J. Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn's Disease. PLoS One 2013, 8:e72739.
11. Gill H., Wu J. Prostate specific antigen: the past, present and future. Curr. Urol. 2013, 6:175-178.
12. Greene K.L., Albertsen P.C., Babaian R.J., Carter H.B., Gann P.H., Han M., Kuban D.A., Sartor A.O., Stanford J.L., Zietman A., Carroll P. Prostate specific antigen best practice statement: 2009 update. J. Urol. 2009, 182:2232-2241.
13. Gudmundsson J., Besenbacher S., Sulem P., Gudbjartsson D.F., Olafsson I., Arinbjarnarson S., Agnarsson B.A., Benediktsdottir K.R., Isaksson H.J., Kostic J.P., Gudjonsson S.A., Stacey S.N., Gylfason A., Sigurdsson A., Holm H., Bjornsdottir U.S., Eyjolfsson G.I., Navarrete S., Fuertes F., Garcia-Prats M.D., Polo E., Checherita I.A., Jinga M., Badea P., Aben K.K., Schalken J.A., van Oort I.M., Sweep F.C., Helfand B.T., Davis M., Donovan J.L., Hamdy F.C., Kristjansson K., Gulcher J.R., Masson G., Kong A., Catalona W.J., Mayordomo J.I., Geirsson G., Einarsson G.V., Barkardottir R.B., Jonsson E., Jinga V., Mates D., Kiemeney L.A., Neal D.E., Thorsteinsdottir U., Rafnar T., Stefansson K. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci. Transl. Med. 2010, 2:62ra92.
14. Hayes J.H., Barry M.J. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA 2014, 311:1143-1149.
15. He J., Shi T.Y., Zhu M.L., Wang M.Y., Li Q.X., Wei Q.Y. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis. Int. J. Cancer 2013, 133:1765-1775.
16. Helfand B.T., Loeb S., Hu Q., Cooper P.R., Roehl K.A., McGuire B.B., Baumann N.A., Catalona W.J. Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies. J. Urol. 2013, 189:1697-1701.
17. Holm K., Melum E., Franke A., Karlsen T.H. SNPexp - a web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinforma. 2010, 11:600.
18. International HapMap Consortium The International HapMap Project. Nature 2003, 426:789-796.
19. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
20. Jesser C., Mucci L., Farmer D., Moon C., Li H., Gaziano J.M., Stampfer M., Ma J., Kantoff P. Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels. Br. J. Cancer 2008, 99:1743-1747.
21. Jin G., Zheng S.L., Lilja H., Kim S.T., Tao S., Gao Z., Young T., Wiklund F., Feng J., Isaacs W.B., Rittmaster R.S., Gronberg H., Condreay L.D., Sun J., Xu J. Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA. Neoplasia 2013, 15:95-101.
22. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24:2938-2939.
23. Kumar P., Henikoff S., Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 2009, 4:1073-1081.
24. Lee Y.H., Kim J.H., Song G.G. Pathway analysis of a genome-wide association study in schizophrenia. Gene 2013, 525:107-115.
25. Nievergelt C.M., Wineinger N.E., Libiger O., Pham P., Zhang G., Baker D.G., Schork N.J. Chip-based direct genotyping of coding variants in genome wide association studies: utility, issues and prospects. Gene 2014, 540:104-109.
26. Nobata S., Hishida A., Naito M., Asai Y., Mori A., Kuwabara M., Katase S., Okada R., Morita E., Kawai S., Hamajima N., Wakai K. Association between KLK3 rs2735839 G/A polymorphism and serum PSA levels in Japanese men. Urol. Int. 2012, 89:39-44.
27. Penney K.L., Schumacher F.R., Kraft P., Mucci L.A., Sesso H.D., Ma J., Niu Y., Cheong J.K., Hunter D.J., Stampfer M.J., Hsu S.I. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. Carcinogenesis 2011, 32:853-859.
28. Pilia G., Chen W.M., Scuteri A., Orru M., Albai G., Dei M., Lai S., Usala G., Lai M., Loi P., Mameli C., Vacca L., Deiana M., Olla N., Masala M., Cao A., Najjar S.S., Terracciano A., Nedorezov T., Sharov A., Zonderman A.B., Abecasis G.R., Costa P., Lakatta E., Schlessinger D. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2006, 2:e132.
29. Schroder F.H., Hugosson J., Roobol M.J., Tammela T.L., Ciatto S., Nelen V., Kwiatkowski M., Lujan M., Lilja H., Zappa M., Denis L.J., Recker F., Paez A., Maattanen L., Bangma C.H., Aus G., Carlsson S., Villers A., Rebillard X., van der Kwast T., Kujala P.M., Blijenberg B.G., Stenman U.H., Huber A., Taari K., Hakama M., Moss S.M., de Koning H.J., Auvinen A. Prostate-cancer mortality at 11years of follow-up. N. Engl. J. Med. 2012, 366:981-990.
30. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014, 64:9-29.
31. Sivonova M.K., Dobrota D., Dusenka R., Waczulikova I., Slezak P., Matakova T., Mahmoodova S., Mistuna D., Kliment J. Effect of CYP17 and PSA gene polymorphisms on prostate cancer risk and circulating PSA levels in the Slovak population. Mol. Biol. Rep. 2012, 39:7871-7880.
32. Sohn Y.S., Tamir S., Song L., Michaeli D., Matouk I., Conlan A.R., Harir Y., Holt S.H., Shulaev V., Paddock M.L., Hochberg A., Cabanchick I.Z., Onuchic J.N., Jennings P.A., Nechushtai R., Mittler R. NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:14676-14681.
33. Song G.G., Lee Y.H. Pathway analysis of genome-wide association studies for Parkinson's disease. Mol. Biol. Rep. 2013, 40:2599-2607.
34. Song G.G., Choi S.J., Ji J.D., Lee Y.H. Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis. Mol. Biol. Rep. 2013, 40:2557-2564.
35. Stephan C., Ralla B., Jung K. Prostate-specific antigen and other serum and urine markers in prostate cancer. Biochim. Biophys. Acta 2014, 1846:99-112.
36. Stranger B.E., Forrest M.S., Dunning M., Ingle C.E., Beazley C., Thorne N., Redon R., Bird C.P., de Grassi A., Lee C., Tyler-Smith C., Carter N., Scherer S.W., Tavare S., Deloukas P., Hurles M.E., Dermitzakis E.T. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007, 315:848-853.
37. Sun J., Tao S., Gao Y., Peng T., Tan A., Zhang H., Yang X., Qin X., Hu Y., Feng J., Kim S.T., Lin X., Wu Y., Zhang J., Li Z., Li L., Mo L., Liang Z., Shi D., Huang Z., Huang X., Liu M., Liu Q., Zhang S., Lilly Zheng S., Xu J., Mo Z. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population. Hum. Genet. 2013, 132:423-429.
38. Terao C., Terada N., Matsuo K., Kawaguchi T., Yoshimura K., Hayashi N., Shimizu M., Soga N., Takahashi M., Nagahama Cohort Study G., Kotoura Y., Yamada R., Ogawa O., Matsuda F. A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population. J. Med. Genet. 2014, 51:530-536.
39. Thompson I.M., Ankerst D.P., Chi C., Lucia M.S., Goodman P.J., Crowley J.J., Parnes H.L., Coltman C.A. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0ng/ml or lower. JAMA 2005, 294:66-70.
40. van der Sijde M.R., Ng A., Fu J. Systems genetics: from GWAS to disease pathways. Biochim. Biophys. Acta 2014, 10.1016/j.bbadis.2014.04.025.
41. Visscher P.M., Brown M.A., McCarthy M.I., Yang J. Five years of GWAS discovery. Am. J. Hum. Genet. 2012, 90:7-24.
42. Wang K., Li M., Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat. Rev. Genet. 2010, 11:843-854.
43. Wang H.M., Chang T.H., Lin F.M., Chao T.H., Huang W.C., Liang C., Chu C.F., Chiu C.M., Wu W.Y., Chen M.C., Weng C.T., Weng S.L., Chiang F.F., Huang H.D. A new method for post Genome-Wide Association Study (GWAS) analysis of colorectal cancer in Taiwan. Gene 2013, 518:107-113.
44. Yue P., Melamud E., Moult J. SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinforma. 2006, 7:166.
45. Zhang K., Chang S., Cui S., Guo L., Zhang L., Wang J. ICSNPathway: identify candidate causal SNPs and pathways from genome-wide association study by one analytical framework. Nucleic Acids Res. 2011, 39:W437-W443.